Neuraxis Inc —— 资产负债表 (NYSE:NRXS) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

新闻

NeurAxis, Inc. (NRXS) Q4 2025 Earnings Call Transcript

The Zacks Analyst Blog Meta, Bank of America, The Procter & Gamble, Espey and NeurAxis

Top Stock Reports for Meta, Bank of America & Procter & Gamble

NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth

Neuraxis股票在获得FDA批准用于腹部疼痛治疗后上涨

Neuraxis stock rises after FDA clearance for abdominal pain treatment

Neuraxis获得FDA批准PENFS设备并扩大市场发行规模

Neuraxis公布2025年第三季度初步财务业绩，运营亏损210万美元

Neuraxis reports preliminary Q3 2025 financial results with $2.1 million operating loss

The Zacks Analyst Blog Highlights Alphabet, IBM, Merck, SandRidge Energy and NeurAxis

Top Research Reports for Alphabet, IBM & Merck

Neuraxis enters $3.3 million at-the-market equity offering agreement